One Step Melanoma Surgery (OSMS) Without Using Ultrasonography for Preoperative Tumour Thickness Measurement? - ʺA Question that Sometimes Drives Me Hazy: Am I or Are the Others Crazy! ʺ
DOI:
https://doi.org/10.3889/oamjms.2018.236Keywords:
Melanoma surgery, One step, Without tumour thickness measurement, Postoperative resultsAbstract
BACKGROUND: One step melanoma surgery is a new surgical approach by which specific groups of patients with cutaneous melanoma may be operated only by or within a single surgical session. Until now, the Bulgarian Society for Dermatologic Surgery (BULSDS) has presented models of clinical behaviour, in which preoperative measurement of tumour thickness in combination with echographic measurement of the locoregional lymph nodes could lead to the conduct of the so-called one-step melanoma surgery. Although this one step surgery currently does not fit in the recommended guidelines, it ensures compliance of the recommended boundaries of operational security while saving patients a repeated excision and relieves the healthcare institutions or the patients themselves financially.
CASE REPORT: We at this moment present another case from the Bulgarian Society for Dermatologic Surgery (BULSDS) of one step melanoma surgery with a perfect end result, where the tumour thickness was not preoperatively determined by high-frequency echography. Preoperative assessment of tumour thickness was performed based on the clinical picture and dermatoscopy. The histologically established tumour thickness was identical to the preoperative assessment, i.e. <1 mm. Removal of the melanocytic lesion was performed with operational security field of 1cm in all directions, where, as a rule, no further removal of the draining lymph nodes is required.
CONCLUSION: Оne step melanoma surgery has two significant advantages: 1) it saves a re-excision in certain groups of patients, which in turn is 2) significantly more favourable from a financial point of view. Its applicability in the appropriate groups of patients and the postoperative (although in a limited number of patients) results achieved indicate the need to optimise the current algorithms and direct them individually to each patient. Guidelines may not and should not be unified or set strict limits given the fact that they show a significant level of variability themselves regarding some key moments in the initial surgical treatment of melanoma. More than 10% of the primary melanoma cases refer to thin melanomas, and dermatoscopy and clinics are a sufficient method of optimising the planned surgical excision.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Tchernev G, Chokoeva A. New Safety Margins for Melanoma Surgery: Nice Possibility for Drinking of "Just That Cup of Coffee"?. Open Access Maced J Med Sci. 2017; 5(3):352-358. https://doi.org/10.3889/oamjms.2017.068
Tchernev G. One Step Melanoma Surgery for Patient with Thick Primary Melanomas: "To Break the Rules, You Must First Master Them!". Open Access Maced J Med Sci. 2018; 6(2): 367–371. https://doi.org/10.3889/oamjms.2018.084 PMid:29531606 PMCid:PMC5839450
Tchernev G. One Step Surgery for Cutaneous Melanoma: "We Cannot Solve Our Problems with the Same Thinking We Used When We Created Them?". Open Access Maced J Med Sci. 2017; 5(6): 774–776. https://doi.org/10.3889/oamjms.2017.168
Tchernev G, Chernin S, Lozev I, Lotti T, Stavrov K, Temelkova I, Pidakev I. Innovative One Step Melanoma Surgical Approach (OSMS): Not a Myth-It's a Reality! Case Related Analysis of a Patient with a Perfect Clinical Outcome Reported from the Bulgarian Society for Dermatologic Surgery (BULSDS)! Open Access Maced J Med Sci. 2018; 6(4):673-674. https://doi.org/10.3889/oamjms.2018.194 PMid:29731939 PMCid:PMC5927502
Leilabadi S, Chen A, Tsai S, Soundararajan V, Silberman H, Wong A. Update and Review on the Surgical Management of Primary Cutaneous Melanoma. Healthcare (Basel). 2014; 2(2):234-49. https://doi.org/10.3390/healthcare2020234 PMid:27429273 PMCid:PMC4934469
Cosimi B, Sober J, Mihm C, Fitzpatrick B. Conservative surgical management of superficially invasive cutaneous melanoma. Cancer. 1984; 53(6):1256-9. https://doi.org/10.1002/1097-0142(19840315)53:6<1256::AID-CNCR2820530607>3.0.CO;2-6
Breslow A, Macht D. Optimal size of resection margin for thin cutaneous melanoma. Surg Gynecol Obstet. 1977; 145(5):691-2. PMid:910211
Machet L, Belot V, Naouri M, Boka M, Mourtada Y, Giraudeau B, Laure B, Perrinaud A, Machet M, Vaillant L. Preoperative measurement of thickness of cutaneous melanoma using high-resolution 20 MHz ultrasound imaging: A monocenter prospective study and systematic review of the literature. Ultrasound Med Biol. 2009; 35(9):1411-20. https://doi.org/10.1016/j.ultrasmedbio.2009.03.018 PMid:19616369
Fernández I, de Troya M, Fúnez R, Rivas F, Blanco G, Blázquez N. Preoperative 15-MHz ultrasound assessment of tumor thickness in malignant melanoma. Actas Dermosifiliogr. 2013; 104(3):227-31. https://doi.org/10.1016/j.adengl.2012.06.025
Chaput L, Laurent E, Pare A, Sallot A, Mourtada Y, Ossant F, Vaillant L, Patat 4, Machet L. One-step surgical removal of cutaneous melanoma with surgical margins based on preoperative ultrasound measurement of the thickness of the melanoma. Eur J Dermatol. 2018; 28(2):202-20. PMid:29620001
Balch M, Urist M, Karakousis P, Smith J, Temple J, Drzewiecki K, Jewell R, Bartolucci A, Mihm Jr, Barnhill R. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg. 1993; 218(3):262-7. https://doi.org/10.1097/00000658-199309000-00005 PMid:8373269 PMCid:PMC1242959
Balch M, Soong J, Bartolucci A, Urist M, Karakousis P, Smith J, Temple J, Ross I, Jewell R, Mihm C, Barnhill L, Wanebo J. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996; 224(3):255-63. https://doi.org/10.1097/00000658-199609000-00002 PMid:8813254 PMCid:PMC1235362
O'Brien O, Lyons T, Murphy S, Feeley L, Power D, Heffron C. BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods. J Clin Pathol. 2017; 70(11):935-940. https://doi.org/10.1136/jclinpath-2017-204367 PMid:28424234
Cheng L, Lopez-Beltran A, Massari F, MacLennan G, Montironi R. Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine. Mod Pathol. 2018; 31(1): 24–38. https://doi.org/10.1038/modpathol.2017.104 PMid:29148538 PMCid:PMC5758899
Hoffend J. Staging of cutaneous malignant melanoma by CT. Radiologe. 2015; 55(2):105-10, 112. https://doi.org/10.1007/s00117-014-2760-1 PMid:25631243
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0